Watchlist Price Alert

NRx Pharmaceuticals Inc. (NRXPW)

NASDAQ: NRXPW · Real-Time Price · USD

0.08

-0.00 (-0.37%)

At close: May 29, 2025, 3:37 PM

0.08

0.00%

After-hours: May 29, 2025, 04:00 PM EDT

NRx Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Cash & Equivalents	1.44M	4.59M	20.05M	27.61M	1.86M	6.00	11.08K	449.37K
Short-Term Investments	n/a	n/a	n/a	n/a	5.97M	32.01M	70.77M	69.03M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	32.01M	70.77M	69.03M
Other Long-Term Assets	349K	431K	21K	15K	11K	n/a	n/a	n/a
Receivables	n/a	6K	n/a	n/a	831K	n/a	n/a	n/a
Inventory	n/a	n/a	-7K	n/a	214K	n/a	n/a	n/a
Other Current Assets	n/a	n/a	5.74M	n/a	26K	n/a	19.11K	87K
Total Current Assets	3.3M	6.88M	25.8M	32.71M	2.93M	69.49K	30.19K	536.38K
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	349K	431K	21K	15K	11K	32.01M	70.77M	69.03M
Total Assets	3.65M	7.32M	25.82M	32.73M	2.94M	32.07M	70.8M	69.57M
Account Payables	4.13M	4.63M	2.08M	3.69M	3.15M	622.44K	551.1K	85.67K
Deferred Revenue	n/a	n/a	n/a	2.84M	n/a	n/a	n/a	n/a
Short-Term Debt	1.57M	9.16M	7.7M	518K	249K	n/a	n/a	n/a
Other Current Liabilities	10.93M	4.42M	5.81M	7.72M	n/a	n/a	n/a	7.5K
Total Current Liabilities	21.86M	19.05M	16.59M	11.92M	46.16M	622.44K	567.41K	93.17K
Long-Term Debt	5.01M	n/a	2.82M	n/a	548K	1.95M	690K	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	5.01M	n/a	1.82M	n/a	548K	1.95M	690K	n/a
Total Liabilities	26.87M	19.05M	18.41M	11.92M	46.71M	2.57M	1.26M	93.17K
Total Debt	6.58M	9.16M	10.53M	518K	797K	1.95M	690K	n/a
Common Stock	15K	84K	67K	59K	43K	24.5M	64.54M	64.48M
Retained Earnings	-278.27M	-253.15M	-223.06M	-183.24M	-90.18M	369.5K	-38.93K	-105.03K
Comprehensive Income	n/a	-3K	n/a	n/a	n/a	-24.5M	n/a	n/a
Shareholders Equity	-23.22M	-11.73M	7.41M	20.81M	-43.77M	29.5M	69.54M	69.47M
Total Investments	n/a	n/a	n/a	n/a	5.97M	32.01M	70.77M	69.03M